🔴 Helius Medical Technologies is trading 5.8% down today as Nasdaq and S&P 500 decline

Helius Medical Technologies is trading 5.8% down at $3.08 amid broader market weakness, after reversing an earlier rally.

• B. Riley Securities raised its price target from $3.50 to $4.00 on September 22, maintaining a Buy rating; that bullish catalyst does not explain the current decline.
• The Nasdaq is down 1.18%, and the S&P 500 is down 0.63%.